Pentwater Capital Management LP Athira Pharma, Inc. Transaction History

Pentwater Capital Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$8.96 - $13.51 $358,400 - $540,400	-40,000 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$9.17 - $16.39 $733,600 - $1.31 Million	-80,000 Reduced 66.67%	40,000 $521,000
Q1 2021 May 17, 2021	BUY	$16.9 - $29.77 $1.69 Million - $2.98 Million	100,000 Added 500.0%	120,000 $2.21 Million
Q3 2020 Nov 16, 2020	BUY	$16.02 - $18.46 $320,400 - $369,200	20,000 New	20,000 $369,000

16.9M

112K

68K

Ticker ATHA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,817,700
Market Cap $24.2M
Description
Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...

Get notified when there are updates to the investment portfolio of Pentwater Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Pentwater Capital Management LP with notifications on news.